MADALYN SZELWACH: Open Payments
NPI 1104501402 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 8 payments from 6 companies in 2025. Trend: 2023 $244 · 2024 $676 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $124 |
| UCB, Inc. | 1 | $97 |
| ABBVIE INC. | 2 | $52 |
| Lilly USA, LLC | 2 | $33 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, EBGLYSS, Zoryve, BLU-U, TALTZ.
Industry payments across NC — which companies pay providers there.
